The Global IVD Antibodies Industry is poised for significant expansion, forecasting an impressive Compound Annual Growth Rate (CAGR) of approximately 3.8% from 2022 to 2032. This upward trajectory is expected to culminate in a valuation of nearly US$2 Billion by the end of the forecast period. The driving force behind this remarkable growth is the …